Actinium Pharmaceuticals, Inc. (ATNM)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

ATNM logo

ATNM Cost of Revenue

Latest reported$0.00
ATNM Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

ATNM cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
220,000
-615,000
0
0
0
204,000
202,000
189,000
216,000
199,000
200,000
209,000
0
161,000
221,000
180,000
137,000
137,000
0
0
0
0
0
0
0
104,361
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.